INOVIQ Ltd (ASX:IIQ – Get Rating) insider Philip (Phil) Powell bought 20,000 shares of the firm's stock in a transaction on Monday, March 6th. The stock was acquired at an average cost of A$0.57 ($0.38) per share, with a total value of A$11,400.00 ($7,651.01).
Philip (Phil) Powell also recently made the following trade(s):
Get
INOVIQ alerts:
- On Wednesday, March 1st, Philip (Phil) Powell purchased 18,518 shares of INOVIQ stock. The shares were acquired at an average cost of A$0.54 ($0.36) per share, with a total value of A$9,999.72 ($6,711.22).
- On Friday, March 3rd, Philip (Phil) Powell purchased 19,481 shares of INOVIQ stock. The shares were acquired at an average cost of A$0.56 ($0.38) per share, with a total value of A$10,909.36 ($7,321.72).
INOVIQ Stock Performance
The company has a debt-to-equity ratio of 3.73, a current ratio of 5.28 and a quick ratio of 9.52.
About INOVIQ
(Get Rating)
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.
Featured Stories
- FuelCell Energy Gains Traction, Shares Surge
- Solo Brands May Remind Investors Why Cash is King
- Someone Is Buying The Dip In MongoDB
- Cameco: Is the New Uranium Bull Market Here to Stay?
- Etsy Stock: Crafty Bargain or Piece of Junk?
Receive News & Ratings for INOVIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INOVIQ and related companies with MarketBeat.com's FREE daily email newsletter.
INOVIQ有限公司(ASX:IIQ-GET Rating)內部人士菲利普(Phil)鮑威爾在3月6日星期一的一筆交易中購買了該公司20,000股股票。收購這只股票的平均成本為每股0.57澳元(0.38美元),總價值為11,400.00澳元(7,651.01美元)。
菲利普(菲爾)鮑威爾最近還進行了以下交易:
到達
INOVIQ警報:
- 3月1日,星期三,菲利普·鮑威爾購買了18,518股INOVIQ股票。這些股票是以每股0.54澳元(0.36美元)的平均成本收購的,總價值為9999.72澳元(6711.22美元)。
- 3月3日,星期五,菲利普·鮑威爾購買了19,481股INOVIQ股票。收購這些股票的平均成本為每股0.56澳元(0.38美元),總價值為10,909.36澳元(7,321.72美元)。
INOVIQ股票表現
該公司的債務權益比為3.73,流動比率為5.28,速動比率為9.52。
關於INOVIQ
(獲取評級)
INOVIQ有限公司致力於診斷和基於外顯子的產品的研究、開發和商業化,以加強澳大利亞和美國對癌症和其他疾病的診斷和治療。該公司提供hTERT檢測,這是一種免疫細胞化學檢測,用於膀胱癌的尿細胞學檢測;以及EXO-Net,用於捕獲和分離液體活檢樣本中的外切體。
專題報道
- FuelCell Energy獲得牽引力,股價飆升
- 獨家品牌可能提醒投資者為什麼現金為王
- 有人在購買MongoDB中的Dip
- Cameco:新的鈾牛市會持續下去嗎?
- Etsy股票:狡猾的討價還價還是垃圾?
接受INOVIQ日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對INOVIQ和相關公司的最新新聞和分析師評級的每日簡明摘要。